Latest Breaking News On - William mcvicar - Page 1 : comparemela.com

Salarius Pharmaceuticals (SLRX) Issues Update on Strategic Review Process, Will Support Ongoing Seclidemstat Clinical Trials by Further Cost Cuts

Salarius Pharmaceuticals (SLRX) Issues Update on Strategic Review Process, Will Support Ongoing Seclidemstat Clinical Trials by Further Cost Cuts
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

William mcvicarDavid arthurSalarius pharmaceuticals incCanaccord genuityMd anderson cancer centerSalarius pharmaceuticalsCancer centerSalariu phaseChief executive officer

Satellos Bioscience Inc : Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan

Satellos Bioscience Inc : Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Brian bloomAdam mostafaRyan mitchellChristina cameronWilliam jaroszJessica yinglingWilliam mcvicarFrank gleesonGeoff mackayFranklinm bergerMichael rudnickiVenture exchangeCommunications at satellos bioscience incCompany stock option planRegulatory services providerBusiness development

Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan

Satellos Bioscience Announces Results from Its Annual General Meeting of Shareholders and Adoption of Amendments to Stock Option Plan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jessica yinglingChristina cameronRyan mitchellAdam mostafaFranklinm bergerMichael rudnickiGeoff mackayFrank gleesonWilliam mcvicarWilliam jaroszBrian bloomCompany theNewsfile corpSatellos bioscience incBusiness developmentVenture exchange

Satellos Bioscience Inc : Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights

- $55 million equity financing closed- Resourced to advance lead drug candidate into clinical trialsToronto, Ontario (Newsfile Corp. - May 30, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos"

Michael rudnickiRyan mitchellChristina cameronFrank gleesonRob hallWilliam jaroszWilliam mcvicarJessica yinglingBloom burton securities incEquity offering the companyVenture exchangeCommunications at satellos bioscience incRegulatory services providerSatellos bioscience incBloom burton coBusiness development

Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights

Satellos Bioscience Announces 2023 Q1 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rob hallMichael rudnickiJessica yinglingWilliam jaroszFrank gleesonChristina cameronRyan mitchellWilliam mcvicarBloom burton securities incNewsfile corpCommunications at satellos bioscience incEquity offering the companyBusiness developmentSatellos bioscience incBloom burton coCommon shares